As of 2025-07-15, the Relative Valuation of Pharmala Biotech Holdings Inc (MDMA.CN) is 0.10 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 CAD, the upside of Pharmala Biotech Holdings Inc based on Relative Valuation is 0.7%.
The range of the Relative Valuation is 0.10 - 0.10 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -5.4x - -5.4x | -5.4x |
| Fair Price | 0.10 - 0.10 | 0.10 |
| Upside | 0.7% - 0.7% | 0.7% |
| Date | P/E |
| 2025-07-10 | -5.36 |
| 2025-07-09 | -5.36 |
| 2025-07-08 | -5.36 |
| 2025-07-07 | -5.36 |
| 2025-07-04 | -5.90 |
| 2025-07-03 | -5.90 |
| 2025-07-02 | -5.63 |
| 2025-06-30 | -6.17 |
| 2025-06-27 | -5.90 |
| 2025-06-26 | -5.09 |
| 2025-06-25 | -4.83 |
| 2025-06-24 | -5.09 |
| 2025-06-23 | -5.09 |
| 2025-06-20 | -5.09 |
| 2025-06-19 | -5.36 |
| 2025-06-18 | -5.36 |
| 2025-06-17 | -5.90 |
| 2025-06-16 | -5.90 |
| 2025-06-13 | -5.63 |
| 2025-06-12 | -5.63 |
| 2025-06-11 | -5.36 |
| 2025-06-10 | -5.63 |
| 2025-06-09 | -5.63 |
| 2025-06-06 | -5.36 |
| 2025-06-05 | -5.63 |
| 2025-06-04 | -4.83 |
| 2025-06-03 | -5.09 |
| 2025-06-02 | -4.83 |
| 2025-05-30 | -5.36 |
| 2025-05-29 | -5.63 |
| 2025-05-28 | -6.43 |
| 2025-05-27 | -6.70 |
| 2025-05-26 | -6.70 |
| 2025-05-23 | -6.97 |
| 2025-05-22 | -6.97 |
| 2025-05-21 | -7.24 |
| 2025-05-20 | -7.24 |
| 2025-05-16 | -7.51 |
| 2025-05-15 | -6.97 |
| 2025-05-14 | -6.97 |
| 2025-05-13 | -7.77 |
| 2025-05-12 | -8.04 |
| 2025-05-09 | -8.04 |
| 2025-05-08 | -6.97 |
| 2025-05-07 | -7.51 |
| 2025-05-06 | -8.04 |
| 2025-05-05 | -8.31 |
| 2025-05-02 | -8.85 |
| 2025-05-01 | -8.04 |
| 2025-04-30 | -8.31 |